BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Saga Continues: Roche (RHHBY)'s Tamiflu No Better Than Tylenol At "Fighting Flu" 4/14/2014  More...
Dendreon Corporation (DNDN) Release: Immune Responses Enhanced And Sustained When PROVENGE® (Sipuleucel-T) Is Given After Androgen Deprivation Therapy In Biochemically-Recurrent Prostate Cancer 4/11/2014  More...
Gilead Sciences, Inc. (GILD)’s Sovaldi® Demonstrates Efficacy And Safety Among Chronic Hepatitis C Patients With Advanced Liver Disease 4/11/2014  More...
FDA Grants Breakthrough Status Designation To Novartis AG (NVS)' Meningitis B Vaccine 4/8/2014  More...
H. Lundbeck A/S (LUN.CO) Release: Treatment With Once-Monthly Abilify Maintena® (Aripiprazole) Significantly Reduces Hospitalisation Rates For Patients With Schizophrenia Compared With Daily Oral Antipsychotics 4/7/2014  More...
Bristol-Myers Squibb Company (BMY)'s Eliquis® Works As Well As Pfizer Inc. (PFE)'s In Head-To-Head Subanalysis Study 3/27/2014  More...
Roche (RHHBY)-Backed Study Finds Tamiflu Saved Lives In Flu Pandemic 3/19/2014  More...
uniQure And Chiesi Farmaceutici SpA Announce Six Year Follow-up Data from Glybera® Treated Patients 3/17/2014  More...
Pfizer Inc. (PFE) Vaccine Prevents Pneumonia In Landmark Study 3/14/2014  More...
Merck & Co., Inc. (MRK) Release: New 96-Week ACTG Study Results Presented At CROI 2014; First Large Study Comparing ISENTRESS® (Raltegravir) Regimen To Two Protease Inhibitor Regimens In Previously Untreated Adults With HIV-1 3/5/2014  More...
Janssen Pharmaceutica N.V. Release: New Data Show XEPLION® Significantly Delays Time To Relapse Compared To Treatment As Usual With Oral Antipsychotic Monotherapy 3/4/2014  More...
Pfizer Inc. (PFE) Revs Up For Testing Of Over-The-Counter Lipitor 3/3/2014  More...
Low-Level Usage Of Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Actos May Still Hold Bladder Cancer Risk: Study 2/28/2014  More...
Baxter International, Inc. (BAX) Presents Data At EAHAD From Long-Term Outcomes Registry Reinforcing Prophylaxis Treatment Experience With ADVATE 2/27/2014  More...
Pfizer Inc. (PFE) Touts Positive Results In Pneumonia Vaccine Post-Approval Study 2/24/2014  More...
Roche (RHHBY) May Share Avastin Brain Cancer Data Amid Conflicting Results 2/21/2014  More...
Bristol-Myers Squibb Company (BMY) And Pfizer Inc. (PFE) Release: In a Subanalysis, Eliquis® (apixaban) Reduced The Risk of Stroke And Demonstrated Fewer Major Bleeding Events Versus Warfarin Consistently Across Age Groups, Including Older Patients With Nonvalvular Atrial Fibrillation 2/21/2014  More...
Innovus Pharma To Exhibit Zestra® Its Clinically Proven Product For Female Sexual Arousal And Desire At The International Society For The Study Of Women's Sexual Health 2014 Annual Meeting In San Diego 2/20/2014  More...
AMAG Pharmaceuticals, Inc. (AMAG) Release: Study Shows Mugard® Is More Effective Than Sham-Control At Reducing Mouth And Throat Soreness Associated With Oral Mucositis In Head And Neck Cancer Patients 2/18/2014  More...
Actelion Ltd. (ALIOF.PK)'s Lung Drug May Face Study Against Gilead Sciences, Inc. (GILD) Rival 2/12/2014  More...
Repros Therapeutics Inc. (RPRX) Reports Findings From The Six Month Study Of Androxal® In Men With Secondary Hypogonadism 2/10/2014  More...
Galderma Pharma S.A. Announces The Publication Of Positive Results Of The Long-Term Study Of Mirvaso® Gel For Treatment Of Persistent Erythema Of Rosacea 1/29/2014  More...
Ranbaxy Laboratories (RANBAXY.BO) Workers Fudged Test Results: FDA 1/28/2014  More...
FDA Approved 188 Drugs Using One Single Study As Evidence 1/23/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Release: Data Demonstrates Key Genes Respond Differently To COPAXONE® (glatiramer acetate injection) Versus A Purported Generic Glatiramer Acetate 1/13/2014  More...
Alkermes plc (ALKS) Announces Advances With Its Late-Stage CNS Pipeline 1/8/2014  More...
German Watchdog Deals Setback To Bayer AG (BAYN.DE) Eye Drug Eylea 1/6/2014  More...
Popular ADHD Drugs May Cause Long Erections: FDA 12/18/2013  More...
Osiris Therapeutics, Inc. (OSIR) Release: Journal Publishes Grafix® Clinical Study For Chronic Wounds 12/18/2013  More...
Can The "Trust Hormone" Make It As A Treatment For Schizophrenia And Autism? 12/13/2013  More...
Supernus Pharmaceuticals (SUPN) Posts Exciting Clinical Data Regarding Trokendi XR™ and Oxtellar XR™ on the Company Website 12/13/2013  More...
AstraZeneca PLC (AZN)'s Arimidex Halves Breast Cancer Risk, Study Finds 12/12/2013  More...
Lundbeck Inc. (LUN.CO) Release: New Study Showed Improvement In Cognitive Performance In Adult Patients Treated With Brintellix® (Vortioxetine) For Acute Episodes Of Major Depression 12/11/2013  More...
Enzymotec Announces Publication Acceptance Of Clinical Study Results On Usage Of Vayacog® In Non-Demented Elderly 12/9/2013  More...
Zealand Pharma  (ZEAL.CO) Informs That New Data Presented At The World Diabetes Congress Support Flexibility In Timing Of Administration For Lyxumia® 12/5/2013  More...
Boehringer Ingelheim Corporation Release: New Study Showed Significant Reduction In Blood Glucose With Linagliptin Alone And In Combination With Metformin In Adults Newly Diagnosed With Type 2 Diabetes 12/3/2013  More...
Janssen Pharmaceutica N.V. Unveils New Data On Xeplion® In Various Stages Of Schizophrenia 12/2/2013  More...
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) 150mg Bid Continues To Be The Only Oral Anticoagulant Which Showed Superior Ischaemic Stroke Reduction Vs. Warfarin In Its Pivotal Study RE-LY® 11/25/2013  More...
AstraZeneca PLC (AZN) Release: NHANES Analyses Reinforce The Need For Education To Help Increased Risk Dyslipidemic Patients Aggressively Treat Their Cholesterol 11/20/2013  More...
Impressive Results From Ibrutinib Study Conducted At John Theurer Cancer Center Lead To FDA Approval Of Imbruvica As A Single Agent For Patients With Mantle Cell Lymphoma 11/19/2013  More...
Boehringer Ingelheim Corporation Planning Two New Global Clinical Trials For Pradaxa® (Dabigatran Etexilate) In Expanded Patient Populations 11/19/2013  More...
First Human Data Show Promise Of Boehringer Ingelheim Corporation’s Specific Antidote For Immediate, Complete And Sustained Reversal Of Pradaxa®-Induced Anticoagulation 11/18/2013  More...
AstraZeneca PLC (AZN) Announces Initiation Of Two Additional Global Studies With Brilinta (Ticagrelor) 11/14/2013  More...
ViroPharma Incorporated (VPHM) Release: Analysis Of Pivotal Study Data Showed Routine Prevention Of Hereditary Angioedema (HAE) Attacks With Cinryze® (C1 Esterase Inhibitor [Human]) Resulted In Improved Health-Related Quality Of Life Outcomes Compared To Acute Therapy With C1 Inhibitor While On Placebo 11/12/2013  More...
EU Agency Questions AstraZeneca PLC (AZN) Over Heart Drug Trial 11/8/2013  More...
Supernus Pharmaceuticals (SUPN) Announces Release of Exciting New Clinical Data on Trokendi XR™ 11/6/2013  More...
Ibuprofen No Good in Treating Colds or Sore Throats, University of Southampton Study 11/5/2013  More...
Sunovion Pharmaceuticals Inc. Announces Publication of Two Pivotal Studies Supporting FDA Approval of Latuda® (lurasidone HCl) as Monotherapy and Adjunctive Therapy in Adult Patients With Bipolar Depression in The American Journal of Psychiatry 11/1/2013  More...
Newly Published Study Finds VIVUS, Inc. (VVUS)'s Qsymia Achieves Greater Weight Loss at Lower Doses Than Either of Its Components as Monotherapy 10/31/2013  More...
Roche (RHHBY)'s Avastin Boosts Survival in Advanced Ovarian Cancer 10/23/2013  More...
Pfizer Inc. (PFE) to Continue Developing Pain Therapeutics (PTIE)'s Painkiller Remoxy®; PTIE Stock Jumps 16.45% on Tuesday 10:44AM ET 10/22/2013  More...
Ariad Pharmaceuticals, Inc. (ARIA) Stock Killed After FDA Places Trials of Inclusig on Hold; Stock Falls -65.99% at Market Close (October 9, 2013) 10/11/2013  More...
VIVUS, Inc. (VVUS) Says Drug Delayed Progression to Diabetes 10/10/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Says Death of MS Patient Not Related to Drug 10/9/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Hot New MS Drug Tecfidera Maintains Efficacy in Long-Term Study 10/7/2013  More...
Boehringer Ingelheim GmbH Release: Better Outcome in Case of Major Bleed for Patients Taking the Anticoagulant Pradaxa® Compared to Warfarin 10/7/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) to Present Further Results of Twenty-Year Open-Label Extension Study of Glatiramer Acetate 20 mg Daily for Relapsing-Remitting Multiple Sclerosis 10/4/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: New TYSABRI® Data Show Earlier Treatment and Longer-Term Use Result in Significant Reductions in MS Disease Activity 10/3/2013  More...
Genzyme Corporation (GENZ) Release: Aubagio® Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study 10/3/2013  More...
Novo Nordisk A/S (NVO) Study Shows Tresiba Efficacy for Diabetes 9/26/2013  More...
Data Show Sanofi (France) (SAN.PA)'s Lyxumia® Added to Basal Insulin Lowered Blood Sugar Especially When Fasting Plasma Glucose Was Controlled 9/24/2013  More...
Pacira Pharmaceuticals, Inc. Release: Study Shows EXPAREL® Provided Improved Pain Control, Shorter Length of Hospital Stay and Substantial Cost Savings Following Total Knee Replacement 9/20/2013  More...
Repros Therapeutics Inc. (RPRX) Reports Preliminary Findings: Second Pivotal Study and 6-Month Safety Study Support Androxal® Approvability 9/17/2013  More...
Roche (RHHBY)'s Perjeta Works in Early-Stage Breast Cancer 9/11/2013  More...
Boehringer Ingelheim Corporation, Pfizer Inc. (PFE) Encounter Conflicting Data on Safety of Spiriva 9/11/2013  More...
FDA Probes Brain Infection in Patient on Novartis AG (NVS)'s MS Drug 9/3/2013  More...
Boehringer Ingelheim Pharmaceuticals, Inc. Announces Plans to Expand Body of Evidence With Novel Cardiovascular Research Supporting Pradaxa® (dabigatran etexilate mesylate) 9/3/2013  More...
AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY): New Diabetes Drug Onglyza Doesn't Raise Heart Attack Risk 9/3/2013  More...
Boehringer Ingelheim GmbH's Respimat Inhaler Meets Safety Goal in Study 9/3/2013  More...
Pfizer Inc. (PFE) Completes Pneumococcal Pneumonia Case Accrual For CAPiTA, Adult Vaccine Clinical Trial of Prevenar 13* 8/29/2013  More...
Allergan Inc. (AGN) Demands the FDA Require Human Trials for Restasis Generics 8/22/2013  More...
Novartis AG (NVS)'s Afinitor® Fails Phase 3 Liver Cancer Trial 8/8/2013  More...
Orexo AB: First Patient Dosed in New Study on Long-Term Adherence to Treatment of Opioid Dependence With Zubsolv® 8/7/2013  More...
Deja Vu: Second Probe Finds Manipulated Trial Data for Novartis AG (NVS) Drug 8/5/2013  More...
New Retrospective Analysis on Galderma Laboratories’ Differin® Gel, 0.3% in Adult Female Acne Patients 8/1/2013  More...
Celgene International Sárl (CELG) Release: Study of REVLIMID® (lenalidomide) in Patients with High-Risk Asymptomatic Smoldering Multiple Myeloma Published in The New England Journal of Medicine 8/1/2013  More...
AstraZeneca PLC (AZN) Release: New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor) 7/31/2013  More...
European Medicines Agency Approves SmPC Change to Baxter International, Inc. (BAX)’s ADVATE to Include Information on PK-Guided Dosing Study 7/22/2013  More...
Roche (RHHBY)'s Avastin as Good as Novartis AG (NVS)'s Lucentis for AMD 7/19/2013  More...
Pacira Pharmaceuticals, Inc. Release: New Study Shows Significant Reduction in Opioids, Length of Hospital Stay and Cost of Care for Patients Receiving EXPAREL® as the Foundation of a Multimodal Postsurgical Pain Regimen 7/18/2013  More...
Novartis AG (NVS) Drug Study Data Manipulated: Kyoto Prefectrual University of Medicine 7/16/2013  More...
Boehringer Ingelheim Corporation Release: Benefits of Pradaxa® Maintained in Difficult to Treat Patients With Atrial Fibrillation and Symptomatic Heart Failure 7/16/2013  More...
Celgene Corporation (CELG)'s Revlimid Improves Survival in Blood Cancer Patients 7/12/2013  More...
Baxter International, Inc. (BAX) Presents ADVATE Data on Prophylaxis Management and Efficacy for Hemophilia A Patients 7/8/2013  More...
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis Equal To Warfarin to Halt Blood Clots 7/2/2013  More...
Merck & Co., Inc. (MRK) Release: FDA Approves New U.S. Labeling for ISENTRESS® (raltegravir) to Include 240-Week Results From STARTMRK Study of ISENTRESS Containing Regimen in Previously Untreated HIV-1 Infected Adult Patients 7/2/2013  More...
Access Pharmaceuticals (ACCP) Announces Positive Top-Line Data From MuGard™ Phase IV Clinical Trial In Oral Mucositis Patients Presented At MASCC/ISOO 2013 Symposium 6/28/2013  More...
Acorda Therapeutics (ACOR) Release: First Study of Diazepam Nasal Spray in People With Epilepsy Shows Feasibility of Dosing During Seizure 6/26/2013  More...
A Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN) Diabetes Trial is a "Dud" 6/24/2013  More...
Merck & Co., Inc. (MRK) Release: New Analysis Shows That Patients With Type 2 Diabetes and Mild Renal Impairment Had Similar Improvement in Blood Sugar Control and Experienced Less Hypoglycemia With JANUVIA® (sitagliptin) Compared to Sulfonylurea 6/24/2013  More...
VIVUS, Inc. (VVUS) Study Shows ED Drug Stendra Effective in 15 Minutes 6/19/2013  More...
Kowa Pharmaceuticals America Release: New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia 6/17/2013  More...
Celgene International Sárl (CELG) Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease 6/17/2013  More...
Boehringer Ingelheim Corporation Release: New Long-Term Data Reinforce Safety Profile of Pradaxa® for Stroke Prevention in AF 6/17/2013  More...
Novo Nordisk A/S (NVO) Release: Victoza® (Liraglutide [rDNA Origin] Injection) Safety Profile Further Supported at Scientific Workshop on Pancreatitis, Diabetes and Pancreatic Cancer 6/14/2013  More...
Gilead Sciences, Inc. (GILD)'s Viread Reduces HIV Risk for Drug Users in Study 6/13/2013  More...
AbbVie (ABBV) Presents First Study Assessing the Role of Predefined Doses of Methotrexate When Used in Combination With HUMIRA™ (adalimumab) for Rheumatoid Arthritis 6/13/2013  More...
Merck & Co., Inc. (MRK) Joins Novo Nordisk A/S (NVO) to Reassure Safety of Diabetes Drugs 6/12/2013  More...
Bristol-Myers Squibb Company (BMY)'s Orencia Matches Abbott Laboratories (ABT)' Humira in Arthritis Study 6/12/2013  More...
Genmab A/S (GEN.CO) Release: Teprotumumab Restarts Clinical Development in New Indication 6/12/2013  More...
Eisai Company, Ltd. (ESALY.PK) Confirms Therapeutic Effects of Lenvatinib in Patients With Melanoma in Strategic Collaboration With Quintiles, Inc. (Q) to Develop Eisai Anticancer Compounds 6/10/2013  More...
Sanofi (France) (SAN.PA) Steps Up Diabetes Drive as Rivals Raise the Stakes 6/10/2013  More...
OXiGENE (OXGN) Announces Publication of Final FACT Study Data in Journal Thyroid Suggest Survival Benefit of ZYBRESTAT® in Patients With Anaplastic Thyroid Cancer 6/10/2013  More...
Alexion Pharmaceuticals Inc. (ALXN) Release: Soliris® Significantly Improved Clinical Outcomes in Patients With aHUS in Pivotal Trials Published in New England Journal of Medicine 6/6/2013  More...
Rebellious FDA Reviewer Insists ARB Heart Drugs Have Cancer Risk 6/3/2013  More...
New Bird Flu Found to be Resistant to Roche (RHHBY)'s Tamiflu 5/30/2013  More...
Prometheus Laboratories Inc. Launches PROCLIVITY 02, a Phase IV Multi-Center Study Comparing the Sequence of Proleukin® (Aldesleukin for Injection) and Yervoy® (Ipilimumab) in Patients With Metastatic Melanoma 5/30/2013  More...
Boehringer Ingelheim Corporation Release: New European Survey Highlights Ischaemic Stroke Protection as Treatment Priority for Patients With Atrial Fibrillation 5/28/2013  More...
Positive Trial Results for Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO)'s Abilify Maintena in Schizophrenia 5/22/2013  More...
"Love Hormone" Promises Safer Births After Pfizer Inc. (PFE) Flop 5/21/2013  More...
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO): Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1 5/21/2013  More...
Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients With Schizophrenia Compared to Seroquel XR® (quetiapine XR) 5/21/2013  More...
Sunovion Pharmaceuticals Inc. Presents Results From a One-year, Large Simple Safety Study of BROVANA® (arformoterol tartrate) Inhalation Solution 5/20/2013  More...
Bristol-Myers Squibb Company (BMY) Drug Cocktail Stymies Melanoma Tumors 5/17/2013  More...
UCB, Inc. (UCBJF.PK) Release: New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome 5/17/2013  More...
Why Does Arena Pharmaceuticals, Inc. (ARNA)'s Obesity Drug Have Abuse Potential? 5/13/2013  More...
US WorldMeds, LLC Release: New Clinical Trial Investigates APOKYN for Treating Debilitating Morning Akinesia in Parkinson’s Disease Patients 5/13/2013  More...
Sex Supplements Often Contain Viagra Ingredients, Pfizer Inc. (PFE) Reveals 5/10/2013  More...
Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin® (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma 5/9/2013  More...
Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) Announce Publication of ARISTOTLE Subanalysis in Circulation 5/7/2013  More...
AlphaMed Release: Study Shows Dual Targeting of HER2 and HR-Positive Metastatic Breast Cancer Improves Survival Rates 5/7/2013  More...
European Medicines Agency Ordered Not to Release AbbVie (ABBV)'s Trial Data, for Now 5/2/2013  More...
Pfizer Inc. (PFE)'s Celebrex Meets Goals in Juvenile Rheumatoid Arthritis Study 4/26/2013  More...
Genzyme Corporation (GENZ) Release: Once-Daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study 4/25/2013  More...
Pacira Pharmaceuticals, Inc. Release: New Data Support the Benefits of EXPAREL for Postsurgical Analgesia Following Aesthetic Plastic Surgery Procedures 4/12/2013  More...
German Cost Regulator Rejects Bayer AG (BAY.F) and Regeneron Pharmaceuticals, Inc. (REGN) Eye Drug 3/20/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Parkinson's Treatment Meets Study Goals 3/20/2013  More...
Ferring Pharmaceuticals Data Suggest Lower Risk of Cardiovascular Events or Deaths in Prostate Cancer Patients Treated With Degarelix Compared to LHRH Agonists 3/18/2013  More...
EU Expands Use of Roche (RHHBY)'s Pegasys in Chronic Hepatitis C 3/18/2013  More...
Merck & Co., Inc. (MRK) Says a Crucial Vytorin Study Will Continue 3/13/2013  More...
AbbVie (ABBV) Seeks to Block Release of Clinical Trial Data 3/11/2013  More...
Pfizer Inc. (PFE)'s Eplerenone May Help Prevent Heart Failure in Acute Heart Attack Patients 3/11/2013  More...
Serious Side Effects Seen With Failed Merck & Co., Inc. (MRK) Niacin Drug 3/11/2013  More...
Roche (RHHBY)'s Rituxan Cures Rare Skin-Blistering Disease in Study 3/8/2013  More...
National Institute for Clinical Excellence (NICE) U-Turn on Novartis AG (NVS)'s Xolair for Asthma 3/7/2013  More...
Kowa Pharmaceuticals America Release: New Superiority Trial Showed LIVALO® (Pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 mg 3/7/2013  More...
Merck & Co., Inc. (MRK)'s Tredaptive Raises Risk of Muscle Pain in Study 2/27/2013  More...
Boehringer Ingelheim Corporation Release: New Findings From Two Studies Support Substantial Benefit of Pradaxa® for Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism 2/21/2013  More...
Cumberland Pharmaceuticals (CPIX) Release: Caldolor® Reduces Pain and Fever in Adult Patients 2/19/2013  More...
Bristol-Myers Squibb Company (BMY) Diabetes Drug Helps Obese Adolescents Lose Weight 2/5/2013  More...
NPS Pharmaceuticals, Inc. (NPSP) Release: New Peer-Reviewed Publication Offers Guidance for Integrating Gattex® (Teduglutide [rDNA origin]) for Injection into Management of Short Bowel Syndrome 1/30/2013  More...
Pfizer Inc. (PFE) Reports Positive Results in Studies of Toviaz, Pristiq, Chantix 1/24/2013  More...
Santarus Inc. (SNTS) and VeroScience Announce Publication of Positive Data From Pivotal CYCLOSET® (bromocriptine mesylate) Efficacy Study 1/23/2013  More...
Novartis AG (NVS) Says Afinitor Reduces Tumors in Rare Genetic Disease 1/11/2013  More...
Merck & Co., Inc. (MRK) Cholesterol Drug Fails; Risks Seen 12/26/2012  More...
Merck & Co., Inc. (MRK)'s Tredaptive is Under Review by European Medicines Agency After Failed Trial 12/26/2012  More...
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS 12/13/2012  More...
Pfizer Inc. (PFE)'s Chantix Produced More Heart Concerns, FDA Says 12/13/2012  More...
Novo Nordisk A/S (NVO) Bets on Turning Victoza Into Obesity Blockbuster 12/12/2012  More...
Celgene (CELG) Release: REVLIMID® and VIDAZA® Combination Therapy Achieves Nearly 30 Percent Complete Response in Untreated Elderly Patients With Acute Myeloid Leukemia 12/11/2012  More...
Genentech (RHHBY)'s Perjeta Extends Life of Breast Cancer Patients by 34 Pct 12/11/2012  More...
Celgene International Sárl (CELG) Release: Analysis of Post-Progression Outcomes in MM-015 Study Presented at the 54th American Society of Hematology Annual Meeting 12/11/2012  More...
Millennium: The Takeda Oncology Company Reports Positive Velcade Trial Data 12/10/2012  More...
Boehringer Ingelheim Corporation Release: Treatment With Pradaxa® Associated With Better Patient Outcomes After a Major Bleeding Event Compared to Warfarin 12/10/2012  More...
GlaxoSmithKline (GSK): We Conducted Paxil Clinical Trial Program Appropriately 12/7/2012  More...
AstraZeneca PLC (AZN) Release: Final Overall Survival Analysis of CONFIRM Shows a 4.1 Month Difference in Median Overall Survival When Using FASLODEX® (fulvestrant) Injection 500 mg Compared With 250 mg.1,2 12/5/2012  More...
Eli Lilly and Company (LLY)'s ED Drug, Cialis, Shows Promise in Rare Muscle Disease 11/30/2012  More...
iCeutica Inc. Commences Clinical Program for Metaxalone SoluMatrix™ 11/30/2012  More...
Digoxin for Atrial Fibrillation Questioned After Deaths, Study Published in the European Heart Journal 11/28/2012  More...
Novo Nordisk A/S (NVO) Says New Data Show Victoza Advantage 11/27/2012  More...
Roche (RHHBY)'s Avastin Shows Mixed Results in Glioblastoma 11/23/2012  More...
Pacira Pharmaceuticals, Inc. Release: New Data Demonstrate Reduction in Opioid Use, Hospital Cost and Length of Stay With EXPAREL as the Foundation of a Multimodal Regimen 11/20/2012  More...
Study Shows Positive Results for Pfizer Inc. (PFE)'s Lyrica 11/19/2012  More...
Pamlab LLC Release: Metanx® Study Published in the American Journal of Pharmacy Benefits Indicates Treatment Lowers the Risk of Hospitalization and Decreases Disease-Related Costs 11/19/2012  More...
Gilead Sciences, Inc. (GILD)'s Once-Daily Single Tablet Regimen Stribild™ Maintains High Viral Suppression Through Two Years of Therapy Among Treatment-Naive HIV Patients 11/15/2012  More...
Gilead Sciences, Inc. (GILD)'s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients 11/15/2012  More...
Bed Bugs Dying After Merck & Co., Inc. (MRK) Drug Suggests Possible Weapon 11/14/2012  More...
OncoSec Medical Inc. Reports Positive Interim Efficacy Results From Phase IV Study of NeoPulse in Skin Cancer Patients 11/14/2012  More...
UCB Group (UCBJF.PK) Announces Data on Cimzia® (certolizumab pegol) for Patients With Moderate to Severe Rheumatoid Arthritis at American College of Rheumatology 2012 Congress 11/13/2012  More...
Savient Pharmaceuticals, Inc. (SVNT) Release: New Data Demonstrate KRYSTEXXA®-Treated Refractory Chronic Gout Patients Experienced Significantly Improved Health-Related Quality of Life 11/13/2012  More...
Bayer Corporation (BAY) Release: New Canadian-Led Global Study of Bayer's Xarelto® (rivaroxaban tablet), Initiated for the Secondary Prevention of Cardiovascular Death, Myocardial Infarction and Stroke in Patients With Coronary or Peripheral Artery Disease 11/13/2012  More...
ViroPharma Incorporated (VPHM)'s Cinryze® (C1 Esterase Inhibitor [Human]) Prophylaxis Study Showed Safety Data of Escalating Doses in Patients With Hereditary Angioedema 11/13/2012  More...
Horizon Pharma, Inc. (HZNP) Presents Clinical Data Demonstrating RAYOS® (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis 11/12/2012  More...
Savient Pharmaceuticals, Inc. (SVNT) Release: New Data Published in Annals of the Rheumatic Diseases Confirm Long-Term Safety and Efficacy of KRYSTEXXA® for the Treatment of Refractory Chronic Gout 11/12/2012  More...
Genentech (RHHBY) Presents Positive Data for Actemra in Rheumatoid Arthritis 11/12/2012  More...
Plexxikon Inc. Announces Three-Year Survival in Zelboraf-Treated Metastatic Melanoma Patients 11/9/2012  More...
Okuvision GmbH Initiates Multi-Center, Post-Market Study 11/8/2012  More...
Eli Lilly and Company (LLY) Release: Cardiovascular Outcome Study on Tradjenta® (Linagliptin) Tablets in Adult Patients With Type 2 Diabetes Completes Enrollment 11/8/2012  More...
Boehringer Ingelheim Corporation Release: RELY-ABLE®: Unprecedented Long-Term Data Support Safety Profile and Sustained Efficacy of Pradaxa® for Stroke Prevention in AF 11/8/2012  More...
Boehringer Ingelheim Corporation Release: Recruitment Complete for Trajenta ® (linagliptin) Cardiovascular Outcome Study in Patients With Type 2 Diabetes 11/8/2012  More...
AstraZeneca PLC (AZN) Release: New PLATO Analysis Evaluates the Influence of High-Sensitivity Troponin Biomarker Status in NSTE-ACS Patients Managed With Revascularization or Medical Management 11/7/2012  More...
Novartis AG (NVS) Drug Works to Treat Rare Cushing's Disease 11/6/2012  More...
Boehringer Ingelheim Corporation Release: Safety and Efficacy of Pradaxa® (dabigatran etexilate) Reconfirmed in Clinical Setting for VTE Prevention After Total Knee or Hip Replacement 11/6/2012  More...
Boehringer Ingelheim GmbH Release: FDA and FDA Reaffirm Important Health Benefits and Safety of Pradaxa® (dabigatran etexilate) for Patients With Atrial Fibrillation 11/5/2012  More...
GlaxoSmithKline (GSK), Roche (RHHBY) Drugs Help Treat Breast Cancer in Brain 11/2/2012  More...
Data in The New England Journal of Medicine Show Novartis AG (NVS) Drug Aclasta® Significantly Reduced the Risk of Fracture in Men With Osteoporosis With Once-Yearly Infusion 11/1/2012  More...
Wealth of Worldwide Evidence on Boehringer Ingelheim GmbH's Pradaxa® Including First Clinical Data on Long-Term Efficacy and Safety of a Novel Oral Anticoagulant to be Presented at American Heart Association Scientific Sessions 10/31/2012  More...
Novartis AG (NVS) Cannibalizes Gleevec to Boost New Cancer Drug 10/29/2012  More...
ASTRO Release: Sildenafil Citrate Improves Overall Sexual Function of Prostate Cancer Patients Receiving Radiation Therapy 10/29/2012  More...
Celgene International Sárl (CELG) Release: ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients 10/25/2012  More...
Eli Lilly and Company (LLY) Release: New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Presented at TCT 10/24/2012  More...
Zogenix, Inc. to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology 10/23/2012  More...
Abbott Laboratories (ABT) Announces Three-Year Long-Term Data Evaluating Efficacy with HUMIRA® (Adalimumab) for Patients With Moderately to Severely Active Ulcerative Colitis 10/23/2012  More...
Sleep Tight: GlaxoSmithKline (GSK) Vaccine Not Linked To Narcolepsy 10/19/2012  More...
Pfizer Inc. (PFE) Kidney Cancer Drug Fails as Initial Treatment 10/18/2012  More...
Eisai Company, Ltd. (ESALY.PK)'s Epilepsy Drug Helps Obese Patients Lose Weight 10/17/2012  More...
Drugs Including Pfizer Inc. (PFE)'s Lipitor Help Cholesterol Declines in U.S. as Obesity Rises 10/17/2012  More...
Abbott Laboratories (ABT)' Hepatitis C Drugs Clear Virus in 99% of Patients 10/16/2012  More...
Pfizer Inc. (PFE) Release: New Study With CHANTIX®/CHAMPIX® (Varenicline) Tablets Suggests Favorable Benefit-Risk Profile in Adult Smokers With Major Depressive Disorder 10/16/2012  More...
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ) Makes Progress With MS Drugs 10/15/2012  More...





 

//-->